Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein

被引:28
作者
Mikata, S
Miyagawa, S
Iwata, K
Nagasawa, S
Hatanaka, M
Matsumoto, M
Kamiike, W
Matsuda, H
Shirakura, R
Seya, T
机构
[1] Ctr Adult Dis, Dept Immunol, Osaka 573, Japan
[2] Osaka Univ, Sch Med, Dept Surg 1, Osaka 565, Japan
[3] Osaka Univ, Sch Med, Biomed Res Ctr, Div Organ Transplantat, Osaka 565, Japan
[4] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan
关键词
D O I
10.1097/00007890-199802150-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Back ground. Human C4b-binding protein (C4bp) functions as a cofactor for factor I in the degradation of C4b and C3b and, in addition, accelerates the rate of decay of the C4b2a complex. Methods. In this study, we constructed a surface-bound form of human C4b-binding protein (C4bp-PI) consisting of a short consensus repeat 1-8 of the alpha-chain of C4bp and a glycosyl phosphatidylinositol (GPI) of the decay-accelerating factor (CD55) and established stable swine endothelial cell (SEC) lines expressing C4bp-PI by transfection of cDNA. Amelioration of complement-mediated lysis by the transfectant molecules was tested as an in vitro hyperacute rejection model of swine to human discordant xenograft, using the lactate dehydrogenase assay. Results. Flowcytometric profiles of the stable SEC lines with C4bp-PI showed a high level of expression of this molecule. The cell lysate of the SEC line with C4bp-PI showed strong cofactor activity in not only C4b but also C3b, whereas the activity of plasma C4bp to bind to C3 was very weak. Approximately 150x10(4) molecules of C4bp-PI per SEC blocked human complement-mediated cell lysis by approximately 75%. Conclusions. The results suggest that the surface-bound form of C4bp will be very useful in clinical xenotransplantation.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 50 条
[41]   THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS [J].
SCATCHARD, G .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1949, 51 (04) :660-672
[42]   HUMAN C4-BINDING PROTEIN .1. ISOLATION AND CHARACTERIZATION [J].
SCHARFSTEIN, J ;
FERREIRA, A ;
GIGLI, I ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) :207-222
[43]   LIMITED PROTEOLYSIS OF COMPLEMENT PROTEIN C3B BY REGULATORY ENZYME C3B INACTIVATOR - ISOLATION AND CHARACTERIZATION OF A BIOLOGICALLY-ACTIVE FRAGMENT, C3D,G [J].
SEYA, T ;
NAGASAWA, S .
JOURNAL OF BIOCHEMISTRY, 1985, 97 (01) :373-382
[44]   HUMAN FACTOR-H AND C4B-BINDING PROTEIN SERVE AS FACTOR-I-COFACTORS BOTH ENCOMPASSING INACTIVATION OF C3B AND C4B [J].
SEYA, T ;
NAKAMURA, K ;
MASAKI, T ;
ICHIHARAITOH, C ;
MATSUMOTO, M ;
NAGASAWA, S .
MOLECULAR IMMUNOLOGY, 1995, 32 (05) :355-360
[45]   PURIFICATION AND FUNCTIONAL-PROPERTIES OF SOLUBLE FORMS OF MEMBRANE COFACTOR PROTEIN (CD46) OF COMPLEMENT - IDENTIFICATION OF FORMS INCREASED IN CANCER-PATIENTS SERA [J].
SEYA, T ;
HARA, T ;
IWATA, K ;
KURIYAMA, S ;
HASEGAWA, T ;
NAGASE, Y ;
MIYAGAWA, S ;
MATSUMOTO, M ;
HATANAKA, M ;
ATKINSON, JP ;
NAGASAWA, S .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (05) :727-736
[46]   PURIFICATION AND CHARACTERIZATION OF A MEMBRANE-PROTEIN (GP45-70) THAT IS A COFACTOR FOR CLEAVAGE OF C3B AND C4B [J].
SEYA, T ;
TURNER, JR ;
ATKINSON, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (04) :837-855
[47]   ISOLATION FROM HUMAN-ERYTHROCYTES OF A NEW MEMBRANE-PROTEIN WHICH INHIBITS THE FORMATION OF COMPLEMENT TRANSMEMBRANE CHANNELS [J].
SUGITA, Y ;
NAKANO, Y ;
TOMITA, M .
JOURNAL OF BIOCHEMISTRY, 1988, 104 (04) :633-637
[48]  
SUZUKI K, 1988, J BIOL CHEM, V263, P17034
[49]   SOLUBLE HUMAN-COMPLEMENT RECEPTOR TYPE-1 - INVIVO INHIBITOR OF COMPLEMENT SUPPRESSING POSTISCHEMIC MYOCARDIAL INFLAMMATION AND NECROSIS [J].
WEISMAN, HF ;
BARTOW, T ;
LEPPO, MK ;
MARSH, HC ;
CARSON, GR ;
CONCINO, MF ;
BOYLE, MP ;
ROUX, KH ;
WEISFELDT, ML ;
FEARON, DT .
SCIENCE, 1990, 249 (4965) :146-151
[50]  
ZICCARDI RJ, 1984, J BIOL CHEM, V259, P3674